» Articles » PMID: 39893486

Scaling Up Access to Antiretroviral Treatment for HIV: Lessons from a Key Populations Program in Nigeria

Overview
Journal AIDS Res Ther
Publisher Biomed Central
Date 2025 Feb 1
PMID 39893486
Authors
Affiliations
Soon will be listed here.
Abstract

Over the years, Nigeria has recorded significant progress in controlling the HIV epidemic in the country. HIV prevalence has reduced from 4.1% in 2010 to 1.4 in 2019. The number of people acquiring new HIV infections decreased from 120,000 in 2010 to 74,000 in 2021, and HIV-related deaths decreased from 82,000 in 2010 to 51,000 in 2021. However, the country still faces challenges such as high HIV transmission among key populations (KP) who account for 11% of new HIV infections. Over the years, the government and development partners involved in HIV response efforts in Nigeria have been establishing and scaling up access to services to help address the needs of KPs. Initially, services for KPs as with the general population in Nigeria were largely preventive. Treatment of PLHIV in Nigeria commenced in 2002 and has increased from about 15,000 to more than 1.78 million PLHIVs in 2023. Despite this progress in treatment coverage, however, KPs are not equitably covered. To address this gap, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) launched an ambitious initiative-the Key Population Investment Fund (KPIF)-to target the unaddressed HIV-related needs of key populations (KPs) who are disproportionately affected by HIV. The KPIF initiative was implemented through partner organizations such as the Society for Family Health (SFH), a KP-friendly and indigenous non-governmental organization. Earlier, the program implemented by SFH was largely an HIV prevention program. SFH's transformation, transition, and growth to a comprehensive HIV prevention, care, and treatment service provider was necessary to bridge the gap in the needed expansion of HIV services to adequately meet the care needs of KPs and scale up programs. Therefore, this paper's aim is to share experiences in the transformation of SFH into a comprehensive HIV prevention, treatment, and care service provider in the hope that it may serve as a lesson for organizations with similar objectives.

Citing Articles

Correction to: Scaling up access to antiretroviral treatment for HIV: lessons from a key populations program in Nigeria.

Salihu A, Jahun I, Oyedeji D, Fajemisin W, Idogho O, Shehu S AIDS Res Ther. 2025; 22(1):23.

PMID: 39994782 PMC: 11853589. DOI: 10.1186/s12981-025-00722-y.

References
1.
Onovo A, Adeyemi A, Onime D, Kalnoky M, Kagniniwa B, Dessie M . Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study. EClinicalMedicine. 2023; 62:102098. PMC: 10393599. DOI: 10.1016/j.eclinm.2023.102098. View

2.
Schwartz S, Nowak R, Orazulike I, Keshinro B, Ake J, Kennedy S . The immediate eff ect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort. Lancet HIV. 2015; 2(7):e299-306. PMC: 4481876. DOI: 10.1016/S2352-3018(15)00078-8. View

3.
Lyons C, Schwartz S, Murray S, Shannon K, Diouf D, Mothopeng T . The role of sex work laws and stigmas in increasing HIV risks among sex workers. Nat Commun. 2020; 11(1):773. PMC: 7028952. DOI: 10.1038/s41467-020-14593-6. View

4.
Reeves A, Steele S, Stuckler D, Mckee M, Amato-Gauci A, Semenza J . National sex work policy and HIV prevalence among sex workers: an ecological regression analysis of 27 European countries. Lancet HIV. 2017; 4(3):e134-e140. DOI: 10.1016/S2352-3018(16)30217-X. View

5.
Azia I, Mukumbang F, van Wyk B . Barriers to adherence to antiretroviral treatment in a regional hospital in Vredenburg, Western Cape, South Africa. South Afr J HIV Med. 2018; 17(1):476. PMC: 5843173. DOI: 10.4102/sajhivmed.v17i1.476. View